Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma

This trial is testing a combination of two experimental drugs (SHR-0302 and SHR-2554) in people with a type of blood cancer called peripheral T-cell lymphoma that has come back or stopped responding to previous treatment. **You may be eligible if...** - You are between 18 and 70 years old - You have been diagnosed with peripheral T-cell lymphoma confirmed by biopsy - The cancer has relapsed or stopped responding to at least one prior treatment - You have measurable disease on imaging - You are in good general health (ECOG score 0 or 1) - You have a life expectancy of at least 12 weeks **You may NOT be eligible if...** - You received anti-cancer treatment in the past 28 days - You had major surgery in the past 4 weeks - You have serious heart, lung, or liver disease - You had a stroke or mini-stroke in the past 6 months - You have an active infection or unexplained fever - You are pregnant - You have a history of alcohol or drug abuse Talk to your doctor to see if this trial is right for you.